申请人:SANDOZ LTD.
公开号:EP0505322A1
公开(公告)日:1992-09-23
Compounds of formula
A-X--Y-NH-B
wherein A is derived from optionally substituted benzothiophene, indole, 4-aza-and 7-aza-benzothiophene or-indole, A bearing in position 5 hydrogen, halogen, optionally substituted alkyl, hydroxy, nitro, amino, alkylamino, acylamino, alcoxycarbonyl, sulfamoyl, cyano, trimethylsilyl, carboxy, carbamoyl, phosphate, oxycarbamoyl, heterocyclic radical or ether or ester group, X---Y is -CR₈=N- or CH(R₈)-NH- wherein R₈ is -H or alkyl and attached at position 3 of A, and B is a heterocyclic radical or a residue
wherein R₁₀ is H, optionally substituted alkyl, cycloalkyl, aryl, adamantyl, acyl or carbamoyl and X₂ is alkylthio or NR₃R₁₀ wherein R₃ is H or alkyl or R₃ and R₁₀ together with the nitrogen atom to which they are attached form a heterocyclic radical, in free form or in salt form, have pharmacological activity, e.g. for treating gastrointestinal disorders.
式的化合物
A-X--Y-NH-B
其中 A 来自任选取代的苯并噻吩、吲哚、4-氮杂和 7-氮杂苯并噻吩或吲哚,A 在第 5 位含有氢、卤素、任选取代的烷基、羟基、硝基、氨基、烷基氨基、酰氨基、烷氧基羰基、氨基磺酰基、氰基、三甲基硅基、羧基、氨基甲酰基、磷酸基、氧氨基甲酰基、杂环基或醚或酯基、氰基、三甲基硅基、羧基、氨基甲酰基、磷酸基、氧氨基甲酰基、杂环基、醚基或酯基,X--Y 是-CR₈=N- 或 CH(R₈)-NH- 其中 R₈ 是-H 或烷基并连接在 A 的第 3 位,B 是杂环基或残基。
其中 R₁₀ 是 H、任选取代的烷基、环烷基、芳基、金刚烷基、酰基或氨基甲酰基、X₂是烷硫基或 NR₃R₁₀,其中 R₃ 是 H 或烷基,或 R₃ 和 R₁₀ 与它们连接的氮原子一起形成杂环基。例如,用于治疗胃肠道疾病。